OTC Markets welcomes Senzime AB to OTCQX Best Market

OTC Markets Group Inc. (OTCQX:OTCM) has announced that Senzime AB (Nasdaq Stockholm: SEZI; OTCQX: SNZZF), a Swedish medical device company, has successfully upgraded to the OTCQX Best Market from the Pink market. Senzime AB now begins trading on OTCQX under the symbol "SNZZF." The move aims to expand the company's international reach, particularly in the crucial U.S. market, as it focuses on addressing postoperative complications. Philip Siberg, CEO of Senzime, is enthusiastic about attracting a broader investor base through this transition.